CIRAX | RALYX | CIRAX / RALYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 2 years | - |
Gain YTD | 11.912 | 10.849 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 109B | 4.37M | 2,495,421% |
Annual Yield % from dividends | 3.25 | 3.07 | 106% |
Returns for 1 year | 18.84 | 15.08 | 125% |
Returns for 3 years | 18.58 | N/A | - |
Returns for 5 years | 39.80 | N/A | - |
Returns for 10 years | 68.88 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OAZBX | 35.94 | 0.02 | +0.06% |
Oakmark Equity and Income R6 | |||
ETNHX | 36.29 | -0.02 | -0.06% |
Eventide Healthcare & Life Sciences N | |||
SBIYX | 11.09 | -0.01 | -0.09% |
ClearBridge International Value I | |||
CLPAX | 12.45 | -0.02 | -0.16% |
Catalyst Nasdaq-100 Hedged Equity A | |||
SBSPX | 43.77 | -0.12 | -0.27% |
Franklin S&P 500 Index A |